SCHEMBL10926166

SCHEMBL10926166

COc1ccc(Sc2ccc(NC(C)=O)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.59
SMN1; SMN2 Q16637 4/20 0.59
RAB9A P51151 3/20 0.59
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
MAPT P10636 3/20 0.57
HSD17B10 Q99714 2/20 0.57
ALDH1A1 P00352 1/20 0.57
HTT P42858 1/20 0.57
MTNR1A P48039 2/20 0.56
MTNR1B P49286 2/20 0.56
IDO1 P14902 1/20 0.56
PTGIR P43119 1/20 0.56
TP53 P04637 2/20 0.54
ALOX15 P16050 1/20 0.54
NPSR1 Q6W5P4 1/20 0.54
LMNA P02545 1/20 0.53
CYP1A2 P05177 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
TGM2 P21980 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171415 0.89 SMN1; SMN2 (0.73) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL3959278 0.87 SMN1; SMN2 (0.64) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL14384396 0.84 MTNR1A (0.76) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL9571811 0.84 MTNR1A (0.71) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL19193312 0.82 MEN1 (0.53) SMN1; SMN2MEN1KMT2AMAPTHSD17B10
SCHEMBL17477113 0.81 KMT2A (0.57) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL11644676 0.81 MTNR1A (0.59) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL6814406 0.81 CYP1A2 (0.69) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL3468387 0.81 MAPT (0.68) NPC1SMN1; SMN2RAB9AMEN1KMT2A
SCHEMBL11481934 0.81 IDO1 (0.66) NPC1SMN1; SMN2RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute CE PHARM CO., LTD. (CN) 2020-09-01 US disclosed
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE CE PHARM CO., LTD. (CN) 2019-05-02 US disclosed
WO-2017177979-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE 中国科学院上海有机化学研究所 2017-10-19 WO disclosed
EP-0102476-B1 METHOD OF MODULATING THE IMMUNE RESPONSE SYSTEM IN MAMMALS AMERICAN CYANAMID COMPANY (US) 1986-11-05 EP disclosed
US-4532349-A 2-Amino-4'(phenylsulfonyl) acetanilides AMERICAN CYANAMID COMPANY (US) 1985-07-30 US disclosed
EP-0102476-A1 Method of modulating the immune response system in mammals AMERICAN CYANAMID COMPANY (US) 1984-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127337-A1 HETEROCYCLIC CARBOXYLIC ACID AMIDE LIGAND AND APPLICATIONS THEREOF IN COPPER CATALYZED COUPLING REACTION OF ARYL HALOGENO SUBSTITUTE AOC1, AOC2, AOC3 NPC1 3545/4885SMN1; SMN2 4066/4885RAB9A 2403/4885
US-10759765-B2 Heterocyclic carboxylic acid amide ligand and applications thereof in copper catalyzed coupling reaction of aryl halogeno substitute AOC1, AOC2, AOC3 NPC1 3545/4885SMN1; SMN2 4066/4885RAB9A 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.